Fulcrum Therapeutics, Inc.
Ticker: 1680581
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY24 | Q2 FY24 | Q3 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q1 FY23 | Q3 FY22 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 80.00+0.0% | 80.00+10426.3% | 0.76+0.0% | 0.76-13.6% | 0.88+193.3% | 0.30+0.0% | 0.30-74.6% | 1.18 |
| Total Income | 80.00+0.0% | 80.00+10426.3% | 0.76+0.0% | 0.76-13.6% | 0.88+193.3% | 0.30+0.0% | 0.30-74.6% | 1.18 |
| EXPENSES | ||||||||
| Expenditure | 27.51+0.0% | 27.51-2.4% | 28.20+0.0% | 28.20+0.1% | 28.17-0.2% | 28.24+0.0% | 28.24+10.6% | 25.54 |
| PROFIT | ||||||||
| Net Profit | 55.41+0.0% | 55.41+330.7% | -24.02+0.0% | -24.02-1.0% | -23.78+4.0% | -24.78+0.0% | -24.78-4.4% | -23.74 |
| KEY METRICS | ||||||||
| OPM % | 65.61% | 65.61%+165.61pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 69.26% | 69.26%+169.26pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.89+0.0% | 0.89+328.2% | -0.39+0.0% | -0.39-2.6% | -0.38+7.3% | -0.41+0.0% | -0.41+19.6% | -0.51 |
Corporate Events
Board MeetingFULC
202616Aug
Board Meeting
Fulcrum Therapeutics, Inc. entered into an Agreement and Pla…
SEC Filing ↗ Board MeetingFULC
20267Aug
Board Meeting
Greg Tourangeau departs as Vice President, Finance and Princ…
SEC Filing ↗ Board MeetingFULC
202624Jun
Board Meeting
Annual Meeting of Stockholders to elect Class I directors, a…
SEC Filing ↗ Board MeetingFULC
20265Jun
Board Meeting
Retention payments and change-in-control benefits approved f…
SEC Filing ↗